-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732.O1.6 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Clinical Outcome: Results of Large Prospective Studies

Symposia: Allogeneic Transplantation: Disease Response and Comparative Treatment Studies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Biological therapies, Lymphoid Leukemias, ALL, clinical trials, adult, Translational Research, Clinical Practice (Health Services and Quality), Combination therapy, Clinical Research, health outcomes research, drug development, Diseases, patient-reported outcomes, Therapies, Immunotherapy, therapy sequence, real-world evidence, Lymphoid Malignancies, Myeloid Malignancies, Study Population, Human, Transplantation
Monday, December 12, 2022: 2:45 PM-4:15 PM
391-392 (Ernest N. Morial Convention Center)
Ioanna Sakellari, Hematology Department - BMT Unit, G. Papanicolaou Hospital and Karen K. Ballen, MD, University of Virginia Health Center
No relevant conflicts of interest to declare.
This oral session describes the clinical outcome after allogeneic transplantation in the setting of large prospective clinical trials. Major randomized trials will be presented, with high clinical relevance for treatment choice strategy in the context of allogeneic transplantation.
2:45 PM

Dietger Niederwieser, MD1, Dirk Hasenclever, PhD2*, Wolfgang E. Berdel, MD3, Bart J Biemond4, Haifa Kathrin Al-Ali, MD5*, Yves Chalandon, MD6,7, Michel Van Gelder, MD, PhD8, Christian Junghanss, MD9*, Goesta Gahrton, MD, PhD10, Mathias Haenel, MD11*, Rüdiger Hehlmann, MD12, Thomas Heinicke, MD13*, Andreas Hochhaus14, Simona Iacobelli15,16*, Rien van Marwijk Kooy17*, Nicolaus Kröger, MD18*, Jeroen J.W.M. Janssen, MD, PhD19*, Madlen Jentzsch, MD20*, Frank Breywisch21*, Mohamad Mohty, MD PhD22, Stavroula Masouridi-Levrat, MD23*, Gert Ossenkoppele, MD, PhD24*, Jakob Passweg, MD25*, Wolfram Pönisch, MD26*, Johannes Schetelig, MD, MSc27, Christoph Schliemann, MD28*, Sebastian Schwind, MD29*, Matthias Stelljes, Prof. Dr. med.30, Peter JM Valk, PhD31, Bob Lowenberg, Prof MD PhD32,33,34 and Jan J. Cornelissen, MD, PhD35

1University Leipzig, Leipzig, DEU
2Institute for Medical Informatics, Statistics and Epidemiology (IMISE) for the Clinical Trial Centre 04107 Leipzig, Germany, University of Leipzig, Leipzig, DEU
3Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany
4Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
5University Leipzig, Leipzig, Germany
6Geneva University Hospitals, Geneva, Switzerland
7Translational Research Center for Oncohematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland
8Department of Hematology, University Hospital Maastricht, Maastricht, Netherlands
9Departement of Medicine III - Hematology, Oncology, and Palliative Care, University of Rostock, Rostock, Germany
10Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
11Department of Hematology, Oncology and Bone Marrow Transplantation, Klinikum Chemnitz, Chemnitz, Germany
12Clinical Investigation Center, European Leukemia Net, Weinheim, Germany
13Department of Hematology and Oncology, University Hospital Magdeburg, Magdeburg, Sachsen-Anhalt, Germany
14Department of Internal Medicine 2, Hematology and Oncology, Jena University Hospital, Jena, Germany
15Department of Biology, Centro Di Biostatistica E Bioinformatica Università Tor Vergata, Rome, Italy
16Rome University Tor Vergata, Rome, Italy
17Isala Ziekenhuis Zwolle, Zwolle, Netherlands
18UKE, Hamburg, AL, DEU
19VU University Medical Center, Amsterdam, NLD
20Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Sachsen, Germany
21Department of Hematology, Oncology and Palliative Care, Ernst Von Bergmann Hospital, Potsdam, DEU
22EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France
23Department of Hematology, Geneva University Hospitals, Geneva, Switzerland
24VU University Medical Centers, Amsterdam University Medical Centers, Amsterdam, Netherlands
25University Hospital, Hematology, Basel, Switzerland, Basel, Switzerland
26Department of Hematology and int. Oncology, University of Leipzig, Leipzig, Germany
27Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
28Department of Hematology, Oncolog and Pneumology, University of Münster, Münster, Germany
29Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Saxonia, Germany
30University of Muenster, Muenster, DEU
31Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
32Erasmus University Medical Center, Rotterdam, NLD
33Erasmus MC Cancer Institute, Rotterdam, Netherlands
34Erasmus University Medical Center Rotterdam and Erasmus MC Cancer Institute, Rotterdam, Netherlands
35Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands

3:00 PM

Richard F. Schlenk, MD1, Pau Montesinos, MD, PhD2*, Antonio Romero-Aguilar, MD3*, Radovan Vrhovac, MD, PhD4*, Elżbieta Patkowska, MD5*, Hee-Je Kim, M.D., Ph.D.6, Pavel Zak, MD, PhD7*, Po-Nan Wang, MD8*, James Hanyok, PharmD9*, Li Liu9*, Yasser Mostafa Kamel, MD10*, Aziz Benzohra9*, Arnaud Lesegretain9*, Jorge E. Cortes, MD11, Mikkael A. Sekeres, MD12, Hervé Dombret, MD, PhD13*, Sergio Amadori, MD14, Jianxiang Wang, MD15, Alexander E. Perl, MD16, Mark J. Levis, MD17 and Harry P. Erba, MD, PhD18

1Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany
2La Fe University and Polytechnic Hospital, Valencia, Spain
3University Hospital Virgen de las Nieves, Granada, Spain
4University Hospital Centre Zagreb, Zagreb, Croatia
5Institute of Hematology and Transfusion Medicine, Warsaw, Poland
6Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
7University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
8Chang Gung Medical Foundation, Linkou, Taiwan
9Daiichi Sankyo, Inc, Basking Ridge, NJ
10Daiichi Sankyo, Inc., Basking Ridge, NJ
11Augusta University Medical Center, Augusta, GA
12University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
13Saint Louis Hospital, University of Paris, Paris, France
14Tor Vergata Polyclinic Hospital Rome, Rome, RM, Italy
15Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
16University of Pennsylvania, Philadelphia, PA
17Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD
18Leukemia Program, Duke University Medical Center, Durham, NC

3:15 PM

Antonio Pierini, MD, PhD1*, Loredana Ruggeri, MD, PhD2*, Simonetta Saldi, MD3*, Sara Tricarico, MD3*, Francesca Marzuttini, MD3*, Valerio Viglione, MD3*, Rebecca Sembenico, MD3*, Tiziana Zei2*, Roberta Iacucci Ostini2*, Antonella Mancusi, PhD1*, Roberto Limongello, MD3*, Olivia Minelli, MD4*, Gianluca Ingrosso, MD, PhD5*, Adelmo Terenzi, MD2*, Maria Paola Martelli, MD, PhD3, Maurizio Caniglia, MD6*, Cristina Mecucci, MD, PhD7, Andrea Velardi, MD1, Massimo Fabrizio Martelli, MD1*, Cynthia Aristei, MD, PhD8* and Alessandra Carotti, MD2*

1Department of Medicine and Surgery, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
2Ospedale Santa Maria della Misericordia, Perugia, Italy
3University of Perugia, Perugia, Italy
4Azienda Ospedaliera di Perugia, Perugia, Italy
5Department of Medicine and Surgery, Division of Radiation Oncology, University of Perugia, Perugia, ITA
6Struttura Complessa Oncoematologia Pediatrica con Trapianto di Midollo Osseo, Azienda Ospedaliera "S. Maria Misericordia" di Perugia, Perugia, Italy
7Department of Medicine and Surgery, University of Perugia, Perugia, Italy
8Department of Medicine and Surgery, Division of Radiation Oncology, University of Perugia, Perugia, Italy

3:30 PM

Gregory A. Abel, MD, MPH1, Haesook T Kim, PhD2, Ira Zackon, MD3, Edwin P. Alyea III, MD4, Alexandra Bailey, MD5*, John P. Winters, MD6, Kenneth R. Meehan, MD7*, John L Reagan, MD8, Jeanna Walsh, MD9*, Meredith Faggen, MD10*, Sarah Sinclair, DO11*, Amy Joyce, NP2*, Sara Close, PA2*, Amy Emmert, MSc2*, Isabella Kallassy, BA2*, John Koreth, MBBS, DPhil2, Joseph H. Antin, MD2, Corey Cutler, MD, MPH, FRCPC2, Vincent T Ho, MD2* and Robert J Soiffer, MD2

1DFCI, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3New York Oncology Hematology, Albany, NY
4Duke University Medical Center, Durham, NC
5Dana-Farber Milford, Milford, MA
6New England Cancer Specialists, Scarborough, ME
7Dartmouth-Hitchcock Medical Center, Lebanon, NH
8Rhode Island Hospital, Providence, RI
9Dana-Farber/New Hampshire Oncology-Hematology, Londonderry, NH
10Dana-Farber South Shore, Weymouth, MA
11Eastern Maine Medical Center/Northern Lights Health, Bangor, ME

3:45 PM

Karthik Nath, MBBS, PhD1*, Jasme Lee, MS2*, Theresa A Elko, MS3*, Lauren Levy3*, Elaina Preston3*, Sean M. Devlin, PhD2*, Doris Ponce, MD4,5, Richard J. Lin, MD4,6, Brian C. Shaffer, MD3,4, Christina Cho, MD3,4, Ioannis Politikos, MD3,4, Ann A Jakubowski, MD PhD3,4, Jae H Park, MD4,7, Raajit K Rampal, MD, PhD4,7, Miguel-Angel Perales, MD4,6, Martin S. Tallman, MD8, Juliet N. Barker, MBBS3,4, Sergio A Giralt, MD3,4, Ellin Berman, MD4,7, Roni Tamari, MD3,4, Eytan Stein, MD4,7 and Boglarka Gyurkocza, MD3,4

1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
3Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Medicine, Weill Cornell Medical College, New York, NY
5MSKCC, New York, NY
6Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

4:00 PM

Elizabeth Krieger, MD1, Rehan Qayyum, MD2* and Amir Ahmed Toor, MD3*

1Virginia Commonwealth University Health System, Richmond, VA
2EVMS, Norfolk, VA
3Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, VA

*signifies non-member of ASH